Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial (Q46973837)
Jump to navigation
Jump to search
scientific article published in November 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial |
scientific article published in November 2005 |
Statements
1 reference
[Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial]. (English)
1 reference
E F M Wouters
1 reference
D S Postma
1 reference
B Fokkens
1 reference
W C Hop
1 reference
J Prins
1 reference
A F Kuipers
1 reference
H R Pasma
1 reference
C A J Hensing
1 reference
E C Creutzberg
1 reference
Cosmic COPD and Serentide: A Multi-Center Intervention and Characterization Study Group
1 reference
1 November 2005
1 reference
1 reference
11
1 reference
6
1 reference
587-589
1 reference
Identifiers
1 reference